NCT00326092CompletedPhase 2
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension
Conditions
Drugs
Trial Snapshot
- Phase
- Phase 2
- Status
- Completed
- Sponsor
- Alcon Research
- Enrollment
- 88
- Locations
- 1
- Primary Endpoint
- Ocular discomfort
Study Overview
Brief Summary
The purpose of this study is to assess the comfort of a glaucoma therapy in patients with open-angle glaucoma or ocular hypertension
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Double
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Adults of either sex and any race diagnosed with open-angle glaucoma (with or without pseudoexfoliation or pigment dispersion component)
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Ocular discomfort
Secondary Outcomes
No secondary outcomes reported
Investigators
Study Sites (1)
Loading locations...
Similar Trials
Completed
Phase 3
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionOpen-angle GlaucomaOcular HypertensionNCT00314158Alcon Research523
Completed
Phase 3
A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionOcular HypertensionOpen-angle GlaucomaNCT00314171Alcon Research437
Completed
Phase 3
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionOcular HypertensionOpen-angle GlaucomaNCT00293761Alcon Research109
Completed
Phase 3
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionOcular HypertensionOpen-angle GlaucomaNCT00293787Alcon Research156
Completed
Phase 3
A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular HypertensionOcular HypertensionOpen-Angle GlaucomaNCT00293800Alcon Research173